Gilgamesh Pharmaceuticals
Gilgamesh is a pioneering early-stage biotech developing novel compounds that build upon the benefits of classic psychedelics with improvements of other components such as safety, tolerability, duration, and efficacy. Mental health worldwide has reached epidemic proportions and novel treatments have not kept pace with the urgent need to treat depression, anxiety, drug addiction and many other devastating diseases. Our purpose is to accelerate treatments and fundamentally improve mental health.
Last updated on
About Gilgamesh Pharmaceuticals
Founded
2019Estimated Revenue
$1M-$10MEmployees
11-50Funding / Mkt. Cap
$69MCategory
Sector
Health CareIndustry Group
Pharmaceuticals, Biotechnology & Life SciencesIndustry
PharmaceuticalsSIC Code
28NAICs Code
32Location
City
New York CityState
New YorkCountry
United StatesGilgamesh Pharmaceuticals
Find your buyer within Gilgamesh Pharmaceuticals